Background & aims: Previous studies have suggested that some plasma phospholipid saturated fatty acids (SFA) are associated with an increased risk of coronary heart disease and hypertension, major risk factors for heart failure (HF). However, little is known about the association between SFA and HF. This study examines associations of individual plasma phospholipid SFA with HF risk in US male physicians. Methods: The current ancillary study used a prospective nested matched case-control design to select 788 cases of incident HF and 788 controls. Plasma phospholipid SFAs were measured using gas chromatography. HF was self-reported on follow-up questionnaires and validated by review of medical records in a subsample. We used conditional logistic regression to estimate relative risks. Results: Mean age was 58.7±8.0 years. One standard deviation higher plasma phospholipid 16:0 was associated with an odds ratio (95% CI) of 1.20 (1.04, 1.38) controlling for established HF risk factors and other SFAs (p=0.042). However, this association was not significant after Bonferroni correction (p>0.008). We did not observe associations between other SFAs (14:0, 15:0, 18:0, 20:0, or 22:0) and HF risk (all p for trend>0.05). Conclusions: Our data suggested no association between plasma phospholipid SFAs and HF in US male physicians.
Bibliographical noteFunding Information:
This ancillary study was funded by grants R01HL092946 and HL092946S1 (Dr Djousse) from the National Heart, Lung, and Blood Institute and the Office of Dietary Supplement, Bethesda, MD . The Physicians' Health Study is supported by grants CA-34944 , CA-40360 , and CA-097193 from the National Cancer Institute and grants HL-26490 and HL- 34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD .
- Heart failure
- Palmitic acid
- Saturated fatty acids